JPRN-UMIN000000552已完成未知
A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix - A phase 2 neoadjuvant chemotherapy for early stage cervical cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Patients with active infections 2)Patients with serious complications(cardiac disease,uncontrolled diabetes mellitus,malignant hypertension,hemorrhagic tendancy) 3)Patients with active concomitant malignancy 4)Patients with interstitial pneumonia or pulmonary fibrosis 5)Patients with massive pleural, cardiac effusion, and/or ascites 6)Patients with unstable angina,history of cardiac infarction within 6 months,or arrhythmia that requires medical treatment 7)Patients with coneraindication to CPT-11or NDP 8)Patients with diarrhea (watery stool) 9)Patients with intestinal paralysis or illeus 10)Patients during pregnancy or breast-feeding,or unwilling to the use of contraception 11)Patients with any history of serious drug reactions or hypersensitivity 12)Patients who are inappropriate to enter this study with any safety reasons,judged by the treating physician
研究者
相似试验
已完成
1 期
A phase I/II study of chemotherapy using Irinotecan, S-1 plus Oxaliplatin (IRISOX therapy) for unresectable pancreatic cancerJPRN-UMIN000016945Department of Gastroenterology Kitasato University School of Medicine25
已完成
2 期
A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancerStage lb2 lla cervical cancer with pelvic lymph node metastasisJPRN-UMIN000003036Japanese Gynecologic Oncology Group63
已完成
2 期
Phase II study of irinotecan in patients with chemotherapy pretreated angiosarcoma.angiosarcomaJPRN-UMIN000008187ational Cancer Center Hospital18
招募中
2 期
Phase II study of irinotecan in patients with chemotherapy pretreated angiosarcoma. The ANGIRI study.AngiosarcomaJPRN-UMIN000002805Masashi Ando18
招募中
2 期
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerC535836pancreatic cancerJPRN-jRCT1041230068Ebata Tomoki50